Suppr超能文献

美国印第安人和阿拉斯加原住民成年人(≥45 岁)中的阿尔茨海默病和相关痴呆诊断,印第安人健康服务系统,2016-2020 年。

Alzheimer's disease and related dementia diagnoses among American Indian and Alaska Native adults aged ≥45 years, Indian Health Service System, 2016-2020.

机构信息

Division of Epidemiology and Disease Prevention, Indian Health Service, Rockville, Maryland, USA.

Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

出版信息

J Am Geriatr Soc. 2024 Sep;72(9):2834-2841. doi: 10.1111/jgs.19058. Epub 2024 Aug 8.

Abstract

BACKGROUND

Alzheimer's disease is the most common type of dementia and is responsible for up to 80% of dementia diagnoses and is the sixth leading cause of death in the United States. An estimated 38,000 American Indian/Alaska Native (AI/AN) people aged ≥65 years were living with Alzheimer's disease and related dementias (ADRD) in 2020, a number expected to double by 2030 and quadruple by 2050. Administrative healthcare data from the Indian Health Service (IHS) were used to estimate ADRD among AI/AN populations.

METHODS

Administrative IHS healthcare data from federal fiscal years 2016 to 2020 from the IHS National Data Warehouse were used to calculate the count and rate per 100,000 AI/AN adults aged ≥45 years with at least one ADRD diagnosis code on their medical record.

RESULTS

This study identified 12,877 AI/AN adults aged ≥45 years with an ADRD diagnosis code, with an overall rate of 514 per 100,000. Of those, 1856 people were aged 45-64. Females were 1.2 times (95% confidence interval: 1.1-1.2) more likely than males to have a medical visit with an ADRD diagnosis code.

CONCLUSIONS

Many AI/AN people with ADRD rely on IHS, tribal, and urban Indian health programs. The high burden of ADRD in AI/AN populations aged 45-64 utilizing IHS health services highlights the need for implementation of ADRD risk reduction strategies and assessment and diagnosis of ADRD in younger AI/AN populations. This study provides a baseline to assess future progress for efforts addressing ADRD in AI/AN communities.

摘要

背景

阿尔茨海默病是最常见的痴呆症类型,占痴呆症诊断的 80%左右,是美国第六大死因。据估计,2020 年有 3.8 万名年龄在 65 岁及以上的美国印第安人/阿拉斯加原住民(AI/AN)患有阿尔茨海默病和相关痴呆症(ADRD),到 2030 年这一数字预计将翻一番,到 2050 年将翻两番。印第安卫生服务局(IHS)的行政医疗保健数据被用于估计 AI/AN 人群中的 ADRD。

方法

本研究使用 IHS 国家数据库中 2016 至 2020 财年的 IHS 行政医疗保健数据,计算每 10 万 45 岁及以上 AI/AN 成年人中至少有一个 ADRD 诊断代码的人数和发病率。

结果

本研究确定了 12877 名年龄在 45 岁及以上的 AI/AN 成年人患有 ADRD 诊断代码,总发病率为 514/10 万。其中 1856 人年龄在 45-64 岁之间。女性患有 ADRD 的医疗就诊次数是男性的 1.2 倍(95%置信区间:1.1-1.2)。

结论

许多患有 ADRD 的 AI/AN 人依赖 IHS、部落和城市印第安人健康计划。45-64 岁 AI/AN 人群中 ADRD 的高负担利用 IHS 卫生服务突出了实施 ADRD 风险降低策略以及在年轻的 AI/AN 人群中评估和诊断 ADRD 的必要性。本研究为评估 AI/AN 社区中 ADRD 工作的未来进展提供了基线。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f14/11875228/3c95ee7ed2c9/nihms-2019995-f0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验